Stryker (SYK) Cash from Investing Activities (QoQ) (2009 - 2026)
Stryker (SYK) Cash from Investing Activities (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -245.41% |
| Mar 31, 2026 | 39.34% |
| Dec 31, 2025 | 4.98% |
| Sep 30, 2025 | -208.65% |
| Jun 30, 2025 | 97.49% |
| Mar 31, 2025 | -1,265.02% |
| Dec 31, 2024 | 86.05% |
| Sep 30, 2024 | -1,756.41% |
| Jun 30, 2024 | 71.32% |
| Mar 31, 2024 | -168.42% |
| Dec 31, 2023 | -4.83% |
| Sep 30, 2023 | 72.80% |
| Jun 30, 2023 | -303.79% |
| Mar 31, 2023 | 18.52% |
| Dec 31, 2022 | -325.00% |
| Sep 30, 2022 | 147.37% |
| Jun 30, 2022 | 94.33% |
| Mar 31, 2022 | -754.14% |
| Dec 31, 2021 | -27.13% |
| Sep 30, 2021 | -22.28% |